| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6193658 | Practical Radiation Oncology | 2013 | 5 Pages |
Abstract
Prophylactic administration of FCZ twice weekly during CRT for head-and-neck cancer reduces incidence of mucositis and thrush.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nikhil G. MD, Gang PhD, John N. MD, Tawee MD, Julie A. MD, Ronald C. MD, Michael D. MD, Ravi MD, PHD, Matthew C. MD, MS, Jimmy J. PhD, MD, Andy M. MD,